CD160 is essential for NK-mediated IFN-γ production

Tu et al. generated a novel CD160-deficient mouse and showed impaired NK cell–mediated tumor elimination and IFN-γ production. CD160+ NK cells are functionally distinct in secretion of IFN-γ from their CD160− NK cell counterparts.

[1]  W. Yokoyama.  Natural killer cell immune responses , 2005, Immunologic research.

[2]  R. Biassoni,et al.  Human natural killer cells: their origin, receptors and function , 2002, European journal of immunology.

[3]  C. Drake,et al.  B and T Lymphocyte Attenuator Exhibits Structural and Expression Polymorphisms and Is Highly Induced in Anergic CD4+ T Cells 1 , 2005, The Journal of Immunology.

[4]  A. Moretta,et al.  NK cells and their receptors during viral infections. , 2011, Immunotherapy.

[5]  R. Biassoni,et al.  Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. , 2001, Annual review of immunology.

[6]  Y. Iwakura,et al.  Inhibition of B16 melanoma experimental metastasis by interferon‐γ through direct inhibition of cell proliferation and activation of antitumour host mechanisms , 2002, Immunology.

[7]  M. Taniguchi,et al.  Protective Roles of B and T Lymphocyte Attenuator in NKT Cell-Mediated Experimental Hepatitis , 2009, The Journal of Immunology.

[8]  S. Valitutti,et al.  CD160-activating NK cell effector functions depend on the phosphatidylinositol 3-kinase recruitment. , 2007, International immunology.

[9]  T. Yamamura,et al.  Murine CD160, Ig-Like Receptor on NK Cells and NKT Cells, Recognizes Classical and Nonclassical MHC Class I and Regulates NK Cell Activation1 , 2005, The Journal of Immunology.

[10]  P. Brodin,et al.  IFN-gamma production and degranulation are differentially regulated in response to stimulation in murine natural killer cells. , 2008, Scandinavian journal of immunology.

[11]  G. Trinchieri,et al.  Biology of Natural Killer Cells , 1989, Advances in Immunology.

[12]  H. Ljunggren,et al.  The RMA‐S lymphoma mutant; consequences of a peptide loading defect on immunological recognition and graft rejection , 1991, International journal of cancer. Supplement = Journal international du cancer. Supplement.

[13]  L. Zender,et al.  T-helper-1-cell cytokines drive cancer into senescence , 2013, Nature.

[14]  C. Benedict,et al.  Evolutionarily divergent herpesviruses modulate T cell activation by targeting the herpesvirus entry mediator cosignaling pathway. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[15]  C. Ware,et al.  B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator , 2005, Nature Immunology.

[16]  M. Shiroishi,et al.  Molecular basis for herpesvirus entry mediator recognition by the human immune inhibitory receptor CD160 and its relationship to the cosignaling molecules BTLA and LIGHT. , 2011, Journal of molecular biology.

[17]  M. Smyth,et al.  An Essential Role for Tumor Necrosis Factor in Natural Killer Cell–mediated Tumor Rejection in the Peritoneum , 1998, The Journal of experimental medicine.

[18]  Nayoung Kim,et al.  Unidirectional signaling triggered through 2B4 (CD244), not CD48, in murine NK cells , 2010, Journal of leukocyte biology.

[19]  M. Colonna,et al.  Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-γ-producing cells. , 2013, Immunity.

[20]  H. Ljunggren,et al.  Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy , 1986, Nature.

[21]  J. Altman,et al.  MHC‐Peptide Tetramers to Visualize Antigen‐Specific T Cells , 2003, Current protocols in immunology.

[22]  G. Leca,et al.  A novel 80-kD cell surface structure identifies human circulating lymphocytes with natural killer activity , 1993, The Journal of experimental medicine.

[23]  M. Colonna,et al.  NK cell-activating receptors require PKC-theta for sustained signaling, transcriptional activation, and IFN-gamma secretion. , 2008, Blood.

[24]  P. Brodin,et al.  IFN‐γ Production and Degranulation are Differentially Regulated in Response to Stimulation in Murine Natural Killer Cells , 2007 .

[25]  Seung Yong Park,et al.  Association with FcRγ Is Essential for Activation Signal through NKR-P1 (CD161) in Natural Killer (NK) Cells and NK1.1+ T Cells , 1997, The Journal of experimental medicine.

[26]  C. Drake,et al.  B and T lymphocyte attenuator exhibits structural and expression polymorphisms and is highly induced in anergic CD4+ T cells , 2005, The Journal of Immunology.

[27]  B. Plougastel,et al.  Immune functions encoded by the natural killer gene complex , 2003, Nature Reviews Immunology.

[28]  G. Freeman,et al.  CD160Ig Fusion Protein Targets a Novel Costimulatory Pathway and Prolongs Allograft Survival , 2013, PloS one.

[29]  J. Strominger,et al.  Signaling at the inhibitory natural killer cell immune synapse regulates lipid raft polarization but not class I MHC clustering , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[30]  F. Mami-Chouaib,et al.  Engagement of CD160 receptor by HLA-C is a triggering mechanism used by circulating natural killer (NK) cells to mediate cytotoxicity , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[31]  K. Murphy,et al.  Cutting Edge: B and T Lymphocyte Attenuator and Programmed Death Receptor-1 Inhibitory Receptors Are Required for Termination of Acute Allergic Airway Inflammation1 , 2006, The Journal of Immunology.

[32]  Tong Zhang,et al.  NK cell receptors as tools in cancer immunotherapy. , 2006, Advances in cancer research.

[33]  Judith E. Cartwright,et al.  Soluble HLA-G1 inhibits angiogenesis through an apoptotic pathway and by direct binding to CD160 receptor expressed by endothelial cells. , 2006, Blood.

[34]  Matthew G. Macauley,et al.  Unconventional ligand activation of herpesvirus entry mediator signals cell survival , 2009, Proceedings of the National Academy of Sciences.

[35]  M. Colonna,et al.  Development and function of murine B220+CD11c+NK1.1+ cells identify them as a subset of NK cells , 2007, The Journal of experimental medicine.

[36]  L. Lanier,et al.  Dysregulation of signaling pathways in CD45-deficient NK cells leads to differentially regulated cytotoxicity and cytokine production. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[37]  K. Pfeffer,et al.  The role of herpesvirus entry mediator as a negative regulator of T cell-mediated responses. , 2005, The Journal of clinical investigation.

[38]  M. Schwaiger,et al.  TNFR1 signaling and IFN-gamma signaling determine whether T cells induce tumor dormancy or promote multistage carcinogenesis. , 2008, Cancer cell.

[39]  Y. Obata,et al.  Characterization of murine CD160+ CD8+ T lymphocytes. , 2006, Immunology letters.

[40]  A. Bensussan,et al.  Identification and Characterization of a Transmembrane Isoform of CD160 (CD160-TM), a Unique Activating Receptor Selectively Expressed upon Human NK Cell Activation1 , 2009, The Journal of Immunology.

[41]  Eric Vivier,et al.  Natural Killer Cell Signaling Pathways , 2004, Science.

[42]  Yang Wang,et al.  B and T Lymphocyte Attenuator Tempers Early Infection Immunity1 , 2009, The Journal of Immunology.

[43]  Lewis L Lanier,et al.  NK cell recognition. , 2005, Annual review of immunology.

[44]  G. Freeman,et al.  Cutting edge: MHC class I triggering by a novel cell surface ligand costimulates proliferation of activated human T cells. , 1999, Journal of immunology.

[45]  J. Kaye,et al.  An Inhibitory Ig Superfamily Protein Expressed by Lymphocytes and APCs Is Also an Early Marker of Thymocyte Positive Selection1 , 2004, The Journal of Immunology.

[46]  J. Gribben,et al.  CD160 signaling mediates PI3K-dependent survival and growth signals in chronic lymphocytic leukemia. , 2010, Blood.

[47]  P. Le Bouteiller,et al.  Cutting Edge: Engagement of CD160 by its HLA-C Physiological Ligand Triggers a Unique Cytokine Profile Secretion in the Cytotoxic Peripheral Blood NK Cell Subset1 , 2004, The Journal of Immunology.

[48]  G. Freeman,et al.  The CD160, BTLA, LIGHT/HVEM pathway: a bidirectional switch regulating T‐cell activation , 2009, Immunological reviews.

[49]  G. Freeman,et al.  CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator , 2008, Nature Immunology.